Actuate Therapeutics, Inc. Common stock (ACTU) insider activity
Actuate Therapeutics, Inc. Common stock (ACTU): 1 insider buy worth $50,000 and 0 sales reported in the last 90 days.
- The CEO bought $50,000 of ACTUATE THERAPEUTICS, INC. stock with their own money. A decent-sized purchase. (2026-10-29)
All insider buys · Legends
TradeTrack shows public SEC filings for general information. It is not investment advice, an offer or a recommendation. Insiders buy and sell for many reasons, past results do not predict future results, and you can lose money.